儿童呼吸道同胞性病毒感染严重疾病的危险因素
O Mendoza-Cano1, X Trujillo2, M Huerta2
1Facultad de Ingeniería Civil, Universidad de Colima, km. 9 Carretera Colima-Coquimatlán, Coquimatlán 28400, Colima, Mexico; Centro de Estudios e Investigación en Biocultura, Agroecología, Ambiente y Salud, Ex Hacienda Nogueras S/N, Nogueras 28450, Mexico.
Public health
|August 14, 2024
概括
这项研究发现,免疫抑制可以保护儿童免受严重的呼吸道同胞病毒 (RSV) 疾病,而延迟寻求医疗保健增加了风险. 这些发现有助于在幼儿中管理RSV感染.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 呼吸道同胞病毒 (RSV) 是幼儿呼吸道疾病的常见原因之一.
- 严重的RSV疾病,包括支气管炎和肺炎,需要住院治疗,并可能对公共卫生产生重大影响.
研究的目的:
- 为了确定与5岁或5岁以下儿童患有实验室确认的RSV感染的严重疾病风险相关的因素.
- 为减轻RSV影响而制定有针对性的干预策略提供信息.
主要方法:
- 在墨西哥进行了一项全国性的回顾性队列研究.
- 分析了2023年1月1日至2024年5月15日期间,实验室确认的RSV感染的5岁或以下的2022名儿童的数据.
- 风险比率 (RR) 和95%置信区间 (CI) 用于评估与严重RSV疾病相关的因素.
主要成果:
- 严重RSV疾病的总体风险为21.0%.
- 个人免疫抑制病史表明,对严重的RSV疾病有保护作用 (RR = 0.14,95% CI 0.05-0.42).
- 症状出现和寻求医疗保健之间的每一个额外的一天都会增加严重RSV疾病的风险 (RR = 1.06,95% CI 1.02-1.10).
结论:
- 这些发现强调了及时寻求RSV症状儿童的医疗保健的重要性.
- 免疫抑制可能会对严重的RSV结果产生保护,这需要进一步调查.
- 这些见解支持风险分层和针对RSV预防和管理在弱势儿科群体的针对性干预措施的发展.
相关概念视频
01:30Pneumonia I: Introduction
215
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
01:29Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
01:17Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
01:21Acute Respiratory Failure-II
187
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
187